Ribbands, Amanda http://orcid.org/0000-0001-9819-8737
Boytsov, Natalie http://orcid.org/0000-0001-7956-5917
Bailey, Abigail http://orcid.org/0000-0002-0238-6723
Gorsh, Boris http://orcid.org/0000-0001-6977-0220
Luke, Emily http://orcid.org/0000-0002-9618-3635
Lambert, Annabel http://orcid.org/0000-0003-4424-1503
Funding for this research was provided by:
GSK
Article History
Received: 4 January 2023
Accepted: 24 May 2023
First Online: 2 June 2023
Declarations
:
: Using a checkbox, patients provided informed consent to take part in the survey. Data were collected in such a way that patients and physicians could not be identified directly.Physician and patient data were pseudo-anonymized. A code was assigned when data were collected. Upon receipt by Adelphi Real World, data were pseudo-anonymized again to mitigate against tracing them back to the individual. Data were aggregated before being shared with the subscriber and/or for publication.This research was submitted to the Western Institutional Review Board, study protocol number AG8847.Data collection was undertaken in line with European Pharmaceutical Marketing Research Association guidelines and as such it did not require ethics committee approval. Each survey was performed in full accordance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act 1996 and Health Information Technology for Economic and Clinical Health Act legislation. Complete descriptions of the DSP methodology and their generalizability have been published [13, 14, 15].
: AR, AB, EL and AL are employees of Adelphi Real World. BG and NB are employees of and hold stocks/shares in GSK.